A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
Key facts
- Who runs it
- Fred Hutchinson Cancer Center
- Where
- Seattle, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 1,178 people, planned
- Started
- 20 May 2026
- Expected to end
- 15 Nov 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Smartphone app
- Text Message
- Survey Administration
- Record updated
- 8 September 2026
Who can take part
- Age
- 18 years to 30 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Age 18-30
- Current weekly user of e-cigarette product(s) for the last 30 days
- Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent)
- Experience downloading and using one or more apps on their smartphone
- Have a mobile data plan and/or access to WiFi to support the use of the ACT on Vaping app
- Has access to text messaging
- Has an email address
- United States (US) resident, with a US mailing address
- Willing to complete all study procedures
- Comfortable reading and writing in English
Who cannot take part
- Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatment is allowable during trial participation)
- Member of the same household as another research participant
- Currently in prison
- Google voice number as sole phone number, due to its association with fraudulent study entry attempts
- Is ineligible per fraud prevention protocol
- Employees/family of investigator or study center
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Nicotine dependence or tobacco-related carcinoma
This trial is currently available in United States.
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, United StatesContact: Jaimee Heffner, PhDTaking people
About the trial
What the trial wants to find out
This clinical trial evaluates a smartphone application (app) called Acceptance and Commitment Therapy (ACT) on Vaping for helping young adults quit using electronic cigarettes (e-cigarettes). E-cigarettes pose numerous risks, particularly to youth and young adults. Addressing the high prevalence of e-cigarette use by young adults requires effective and accessible treatments to support current users to quit. Research shows this group prefers and benefits from newer methods of treatment delivery such as digital interventions. ACT on Vaping is a digital therapeutic intended to deliver behavioral therapy to young adults who vape to motivate and support abstinence from all nicotine and tobacco products. The app contains sessions that promote awareness of cues that trigger tobacco use and teach skills for responding to these triggers in a way that is tailored for the participant's readiness to quit. Receiving access to the ACT on Vaping app may be effective in helping young adults quit vaping.
The 2 groups in the trial
- Arm I (ACT on Vaping app (Version A) + incentivized texts + intervention texts)Treatment being tested
Participants receive access to the ACT on Vaping app utilizing Acceptance and Commitment Therapy. Participants also receive text message intervention content, as well as incentivized text message check-ins at 2 weeks, 2 months, and 4 months to assess changes in vaping on study.
Treatment: Smartphone app, Text Message, and Survey Administration
- Arm II (ACT on Vaping app (Version B) + incentivized texts)Sham treatment, for comparison
Participants receive access to the ACT on Vaping app including health education content. Participants receive incentivized text message check-ins at 2 weeks, 2 months, and 4 months to assess changes in vaping on study.
Treatment: Smartphone app, Text Message, and Survey Administration
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation
- Criteria questions
- Built from NCT06909500, who can take part
- Record updated
- 8 September 2026